A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.

Studies of hereditary cancer syndromes have contributed greatly to our understanding of molecular events involved in tumorigenesis. Here we investigate the molecular background of the Peutz-Jeghers syndrome (PJS), a rare hereditary disease in which there is predisposition to benign and malignant tum...

Full description

Bibliographic Details
Main Authors: Hemminki, A, Markie, D, Tomlinson, I, Avizienyte, E, Roth, S, Loukola, A, Bignell, G, Warren, W, Aminoff, M, Höglund, P, Järvinen, H, Kristo, P, Pelin, K, Ridanpää, M, Salovaara, R, Toro, T, Bodmer, W, Olschwang, S, Olsen, A, Stratton, MR, de la Chapelle, A, Aaltonen, L
Format: Journal article
Language:English
Published: 1998
Description
Summary:Studies of hereditary cancer syndromes have contributed greatly to our understanding of molecular events involved in tumorigenesis. Here we investigate the molecular background of the Peutz-Jeghers syndrome (PJS), a rare hereditary disease in which there is predisposition to benign and malignant tumours of many organ systems. A locus for this condition was recently assigned to chromosome 19p. We have identified truncating germline mutations in a gene residing on chromosome 19p in multiple individuals affected by PJS. This previously identified but unmapped gene, LKB1, has strong homology to a cytoplasmic Xenopus serine/threonine protein kinase XEEK1, and weaker similarity to many other protein kinases. Peutz-Jeghers syndrome is therefore the first cancer-susceptibility syndrome to be identified that is due to inactivating mutations in a protein kinase.